[1] |
WANG Qing-feng, WANG Jun, WANG Jing, DUAN Hong-fei, GE Qi-ping, HUANG Xue-rui, DU Ya-dong, HAN Xi-qin, CHU Nai-hui.
Study on the efficacy of antituberculosis regimens containing different dosage of levofloxacin in patients with MDR-TB
[J]. Chinese Journal of Antituberculosis, 2015, 37(2): 161-166.
|
[2] |
WANG Qian, SONG Yuan-yuan, PANG Yu, WANG Yu-feng, OUYANG Qin, ZHAO Yan-lin.
Study on the cross-resistance among 5 different fluroquinolones in ofloxacin-resistant Mycobacterium tuberculosis isolates
[J]. Chinese Journal of Antituberculosis, 2014, 36(6): 453-457.
|
[3] |
LI Shi-lai, CHEN Wei-sheng, HUANG Yao-fan, LIN Shao-yun, WU Shao-yi, CAI Qing-he.
Observation on the effect on the retreated tuberculosis patients by levofloxacin combined with rifabutin
[J]. Chinese Journal of Antituberculosis, 2014, 36(5): 375-379.
|
[4] |
Wang Qing,Xu Dongfang.
Detection of ofloxacin resistance in M.tuberculosisby phage-amplified biologically assay
[J]. Chinese Journal of Antituberculosis, 2011, 33(1): 43-46.
|
[5] |
LI Guo-Li, CHEN Peng, SUN Chang-Wen, ZHANG Ling-Xia, LI Bang-Yin, ZHAO Yan-Lin.
The cross-resistance to levofloxacin and moxifloxacin in Mycobacteriu tuberculosis and gene mutations in gyrA and gyrB
[J]. Chinese Journal of Antituberculosis, 2010, 32(10): 14-19.
|
[6] |
Yan Liping, Xiao Heping.
Clinical monitor and analysis on Ofloxacin resistance of pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2009, 31(8): 477-480.
|
[7] |
Zhao Weijie,Li Peng,Lu Yu.
Study on the cross-resistance of moxifloxacin and levofloxacin in Mycobacterium tuberculosis
[J]. Chinese Journal of Antituberculosis, 2009, 31(8): 469-472.
|
[8] |
Yang Lijuan.
Meta-analysis on clinical efficacy of combination regimens with levofloxacin in retreatment of pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2009, 31(7): 415-419.
|
[9] |
Liang Jianqin, Wang Jinhe, Wang Wei, Zhang Guangyu, Wang Ansheng, Chen Zhi,Feng Shisheng, Wang Ruilan.
Analysis on 59 patients with pulmonary tuberculosis complicated with corticosteroids
[J]. Chinese Journal of Antituberculosis, 2009, 31(5): 298-300.
|
[10] |
Xu Jintian.
Analysis of the therapeatical effect of levofloxacin on superficial lymphous tuberculosis
[J]. Chinese Journal of Antituberculosis, 2007, 29(3): 247-249.
|
[11] |
Gao Chunrong,Yuan Dongyun,Xu Lijiang..
The short-term treatment effect of regimen which contains the Amikacin Sulfate and the Levofloxacin for multi-drug resistant pulmonary tuberculosis cases (MDR-TB)
[J]. Chinese Journal of Antituberculosis, 2004, 26(3): 165-167.
|
[12] |
GUO Lei, MA Juan-mei , YUAN Jun-ping..
The effect of Levofloxacin on treating MDR-TB
[J]. Chinese Journal of Antituberculosis, 2003, 25(4): 254-256.
|
[13] |
WANG Wei,YE Yi-xiu,YAO Hao,et al..
Evaluation and observation of serum thd parathyroid hormone in patients with severe acute respiratory syndrome
[J]. Chinese Journal of Antituberculosis, 2003, 25(4): 232-234.
|
[14] |
MA Liping,WANG Qingfeng,Wu Xiaoguang..
Controlled clinical study on efficacy of Levofloxacin in treating pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2000, 22(2): 63-65.
|
[15] |
Tang Shenjie,Pan Jinfeng,Huang Cailiu, et al..
Observation of therapeutic effects of ciprofloxacin on multidrug resistant pulmonary tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 1999, 21(2): 87-88.
|